{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:04:27Z","timestamp":1777417467584,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.eururo.2006.07.017","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T14:32:35Z","timestamp":1154529155000},"page":"675-683","source":"Crossref","is-referenced-by-count":68,"title":["Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: A Systematic Review"],"prefix":"10.1016","volume":"50","author":[{"given":"Giacomo","family":"Novara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Galfano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Ficarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Artibani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.07.017_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/bmj.308.6934.929","article-title":"New words for old: lower urinary tract symptoms for \u201cprostatism\u201d","volume":"308","author":"Abrams","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2006.07.017_bib2","series-title":"Benign Prostatic Hyperplasia","first-page":"227","article-title":"The urodynamic assessment of lower urinary tract symptoms (committee 7)","author":"Abrams","year":"2001"},{"key":"10.1016\/j.eururo.2006.07.017_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurol Urodyn"},{"key":"10.1016\/j.eururo.2006.07.017_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00042307-200401000-00003","article-title":"Does anticholinergic medication have a role for men with lower urinary tract symptoms\/benign prostatic hyperplasia either alone or in combination with other agents?","volume":"14","author":"Reynard","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.urology.2003.09.030","article-title":"Storage and voiding symptoms: pathophysiologic aspects","volume":"62","author":"Andersson","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.07.017_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0302-2838(02)00540-7","article-title":"Antimuscarinics and the overactive detrusor\u2014which is the main mechanism of action?","volume":"43","author":"Andersson","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib7","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0022-5347(05)67776-2","article-title":"Correlation between the structure and function of the rabbit urinary bladder following partial outlet obstruction","volume":"163","author":"Gosling","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(97)00038-7","article-title":"Smooth muscle of the bladder in the normal and the diseased state: pathophysiology, diagnosis and treatment","volume":"75","author":"Turner","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.eururo.2006.07.017_bib9","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/01.ju.0000067541.73285.eb","article-title":"Combination treatment with an \u03b1-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study","volume":"169","author":"Athanasopoulos","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"Lee","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.07.017_bib11","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/01.ju.0000173630.94559.fd","volume":"174","author":"Lee","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib12","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/01.ju.0000181823.33224.a0","article-title":"Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"174","author":"Kaplan","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1464-410X.2004.05022.x","article-title":"Pharmacological therapy of benign prostatic hyperplasia\/lower urinary tract symptoms: an overview for the practising clinician","volume":"94","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.07.017_bib15","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1517\/14656566.6.14.2429","article-title":"Efficacy of the combination of an alpha(1)-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction","volume":"6","author":"Athanasopoulos","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eururo.2006.07.017_bib16","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/01.ju.0000176460.62847.23","article-title":"Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction","volume":"174","author":"Ruggieri","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib17","first-page":"1048","article-title":"Tolterodine therapy in men with bladder outlet obstruction and symptomatic detrusor overactivity is not associated with urinary safety concerns [abstract]","volume":"167","author":"Abrams","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-5347(18)38166-7","article-title":"Use of muscarinic receptor antagonists as monotherapy in men with lower urinary tract symptoms who failed previous therapy with alpha blockers [abstract]","volume":"171","author":"Kaplan","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib19","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0022-5347(18)38583-5","article-title":"Propiverine hydrochloride relieves irritative symptoms of benign prostatic hyperplasia [abstract]","volume":"171","author":"Okada","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.eururo.2006.07.017_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1569-9056(02)80513-9","article-title":"Safety of tolterodine in men with bladder outlet obstruction (BOO) and symptomatic detrusor overactivity [abstract]","volume":"1","author":"Abrams","year":"2002","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2006.07.017_bib21","doi-asserted-by":"crossref","unstructured":"Athanasopoulos A, Gyftopoulos K, Giannitsas K, Fisfis I, Perimenis P, Barbalias G. Combination treatment with an \u03b1-blocker plus an anticholinergic improves quality of life in patients with bladder outlet obstruction. a prospective, randomized, controlled study. 2002 ICS annual meeting [abstract 19].","DOI":"10.1097\/01.ju.0000067541.73285.eb"},{"key":"10.1016\/j.eururo.2006.07.017_bib22","unstructured":"Lee KS, Kim DY2, Kim JC, et al. Combination treatment with propiverine hydrochloride plus doxazosin gits in men with overactive bladder coexisting benign prostatic obstruction: a prospective, randomized, controlled, multicenter study. 2004 ICS annual meeting [abstract 207]."},{"key":"10.1016\/j.eururo.2006.07.017_bib23","unstructured":"Suzuki Y, Takasaka S, Kishimoto K, et al. Combination treatment with an alpha1-blocker plus an anticholinergic for the patients with suspected bladder outlet obstruction (boo) concomitant with over-active bladder (OAB). 2004 ICS annual meeting [abstract 471]."},{"key":"10.1016\/j.eururo.2006.07.017_bib24","unstructured":"Alloussi S, Igawa Y, Saito H, et al. Bladder outlet obstruction and symptomatic overactive bladder\u2014contraindication for antimuscarinics? A study review on propiverine. 2005 ICS annual meeting [abstract 148]."},{"key":"10.1016\/j.eururo.2006.07.017_bib25","unstructured":"Lim E, Chia SJ. Combination therapy using alpha-blocker and antimuscarinic drugs in men with lower urinary tract symptoms suggestive of bladder outlet obstruction and an overactive bladder: is it safe and efficacious? 2005 ICS annual meeting [abstract 205]."},{"key":"10.1016\/j.eururo.2006.07.017_bib26","first-page":"525","article-title":"A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and\/or urinary incontinence","volume":"12","author":"Saito","year":"1999","journal-title":"Jpn J Urol Surg"},{"key":"10.1016\/j.eururo.2006.07.017_bib27","unstructured":"Phillips B, Ball C, Sackett D, et al. Levels of evidence and grades of recommendation. Oxford Centre for Evidence-based Medicine. Downloaded at http:\/\/www.cebm.net\/levels_of_evidence.asp."},{"key":"10.1016\/j.eururo.2006.07.017_bib28","series-title":"Randomised controlled trials","author":"Jadad","year":"1998"},{"key":"10.1016\/j.eururo.2006.07.017_bib29","first-page":"2275","article-title":"Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"174","author":"O\u2019Leary","year":"2005","journal-title":"Editorial comment J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib30","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.1995.03530180050029","article-title":"Subverting randomization in controlled trials","volume":"274","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2006.07.017_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"Editorial Comment on Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder","volume":"49","author":"Ficarra","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1474-4422(03)00622-7","article-title":"Antimuscarinics for treatment of overactive bladder","volume":"3","author":"Andersson","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eururo.2006.07.017_bib33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.eursup.2006.02.005","article-title":"Critical review of Guidelines for BPH diagnosis and treatment strategy","volume":"5","author":"Novara","year":"2006","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2006.07.017_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","article-title":"AUA Guideline on Management of Benign Prostatic Hyperplasia (2003). Diagnosis and treatment recommendations","volume":"170","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.07.017_bib35","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1464-410X.2004.04765.x","article-title":"Guideline for the primary care management of male lower urinary tract symptoms","volume":"93","author":"Speakman","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.07.017_bib36","doi-asserted-by":"crossref","unstructured":"Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004;46:547\u201354. Available also at http:\/\/www.uroweb.org.","DOI":"10.1016\/j.eururo.2004.07.016"},{"key":"10.1016\/j.eururo.2006.07.017_bib37","unstructured":"Clinical Practice Guidelines. The management of uncomplicated lower urinary tract symptoms in men. National Health and Medical Research Council, p. 16. Downloaded at http:\/\/www.nhmrc.gov.au\/publications\/pdf\/cp42.pdf (April 2005)."}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806008530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806008530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T13:22:21Z","timestamp":1555766541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806008530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0302283806008530"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.07.017","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}